$400 Million


At-the-market Offering

Tilray is pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and it intends to become a leader in the adult-use cannabis market in Canada. Tilray currently produces and sells its products in accordance with the Access to Cannabis for Medical Purposes Regulations (ACMPR) as set by Health Canada, Canada's federal department of health. Tilray supplies high-quality cannabis products to tens of thousands of patients across the globe through its subsidiaries in Australia, Canada, Germany and Portugal and through established pharmaceutical distributors